Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000241:Adenosine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004357:Drug Synergism; D004423:Ear / Q000187:drug effects*; D004600:Eledoisin / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D010121:Oxytocin / Q000494:pharmacology; D010146:Pain / Q000139:chemically induced*; D010455:Peptides / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D011984:Sensory Receptor Cells / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology; D014690:Venous Pressure / Q000187:drug effects
D010455:Peptides; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D013373:Substance P; D010121:Oxytocin; D011189:Potassium Chloride; D004600:Eledoisin; D006632:Histamine; D000255:Adenosine Triphosphate; D000241:Adenosine; D000109:Acetylcholine; D004837:Epinephrine